GILEAD SCIENCES, INC. Additional Paid-in Capital 2008-2026 | GILD
Beta
What is GILEAD SCIENCES, INC.'s current additional paid-in capital?
GILEAD SCIENCES, INC. (GILD) annual additional paid-in capital for 2025 was $8.93B, a 16.00% increase from 2024. GILEAD SCIENCES, INC. additional paid-in capital for the quarter ending March 31, 2026 was $9.30B.
What was GILEAD SCIENCES, INC.'s additional paid-in capital in 2024?
GILEAD SCIENCES, INC. annual additional paid-in capital for 2024 was $7.70B, a 18.46% increase from 2023.
What was GILEAD SCIENCES, INC.'s additional paid-in capital in 2023?
GILEAD SCIENCES, INC. annual additional paid-in capital for 2023 was $6.50B, a 17.12% increase from 2022.
What is GILEAD SCIENCES, INC.'s 5-year additional paid-in capital CAGR?
GILEAD SCIENCES, INC. additional paid-in capital grew at a compound annual growth rate (CAGR) of 18.15% from FY2020 to FY2025, going from $3.88B to $8.93B over 5 years.
Additional Paid-in Capital History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+18.1%
FY2020
$3.88B
→
FY2025
$8.93B
080910111213141516171819202122232425
5 years selected
Additional Paid-in Capital History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $8.93B | +16.0% | 10-K |
| FY2024 | $7.70B | +18.5% | 10-K |
| FY2023 | $6.50B | +17.1% | 10-K |
| FY2022 | $5.55B | +19.1% | 10-K |
| FY2021 | $4.66B | +20.1% | 10-K |
| FY2020 | $3.88B | +27.2% | 10-K |
| FY2019 | $3.05B | +33.7% | 10-K |
| FY2018 | $2.28B | +80.5% | 10-K |
| FY2017 | $1.26B | +178.4% | 10-K |
| FY2016 | $454.0M | +2.3% | 10-K |
| FY2015 | $444.0M | -81.4% | 10-K |
| FY2014 | $2.39B | -55.6% | 10-K |
| FY2013 | $5.39B | -4.5% | 10-K |
| FY2012 | $5.64B | +15.1% | 10-K |
| FY2011 | $4.90B | +5.5% | 10-K |
| FY2010 | $4.65B | +6.2% | 10-K |
| FY2009 | $4.38B | +11.4% | 10-K |
| FY2008 | $3.93B | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →